OBJECTIVE: Alterations in coagulation, including elevated pulmonary and systemic concentrations of urokinase, are frequent in patients with acute lung injury (ALI). Urokinase potentiates neutrophil activation and contributes to the severity of pulmonary injury in preclinical models of ALI. The objective of this study was to examine associations between polymorphisms and haplotypes of urokinase with risk for and outcomes from ALI. DESIGN: Prospective cohorts of healthy European-American adults and those with infection-associated ALI. SETTING: Academic medical centers participating in NIH funded studies of low tidal volume ventilation for ALI. PATIENTS: Controls were 175 healthy European-American subjects. Patients were 252 individuals with infection-associated ALI, prospectively followed for 60 days for mortality. INTERVENTIONS: Genetic polymorphisms and haplotypes in the urokinase gene were determined. MEASUREMENTS AND MAIN RESULTS: Six polymorphisms, rs1916341, rs2227562, rs2227564, rs2227566, rs2227571, and rs4065, defining 98% of all urokinase haplotypes, were analyzed. There were no statistically significant associations between any single urokinase polymorphism or haplotype and risk for developing ALI. In contrast, there was a statistically significant relationship between the CGCCCC haplotype and both 60-day mortality and ventilator-free days that remained present in a multivariate analysis controlling for age and sex (p=0.033 for 60-day mortality and <0.001 for ventilator-free days). CONCLUSIONS: These results identify a specific urokinase haplotype as a genetic risk factor for higher mortality and more severe clinical outcome in patients with infection-associated ALI.
OBJECTIVE: Alterations in coagulation, including elevated pulmonary and systemic concentrations of urokinase, are frequent in patients with acute lung injury (ALI). Urokinase potentiates neutrophil activation and contributes to the severity of pulmonary injury in preclinical models of ALI. The objective of this study was to examine associations between polymorphisms and haplotypes of urokinase with risk for and outcomes from ALI. DESIGN: Prospective cohorts of healthy European-American adults and those with infection-associated ALI. SETTING: Academic medical centers participating in NIH funded studies of low tidal volume ventilation for ALI. PATIENTS: Controls were 175 healthy European-American subjects. Patients were 252 individuals with infection-associated ALI, prospectively followed for 60 days for mortality. INTERVENTIONS: Genetic polymorphisms and haplotypes in the urokinase gene were determined. MEASUREMENTS AND MAIN RESULTS: Six polymorphisms, rs1916341, rs2227562, rs2227564, rs2227566, rs2227571, and rs4065, defining 98% of all urokinase haplotypes, were analyzed. There were no statistically significant associations between any single urokinase polymorphism or haplotype and risk for developing ALI. In contrast, there was a statistically significant relationship between the CGCCCC haplotype and both 60-day mortality and ventilator-free days that remained present in a multivariate analysis controlling for age and sex (p=0.033 for 60-day mortality and <0.001 for ventilator-free days). CONCLUSIONS: These results identify a specific urokinase haplotype as a genetic risk factor for higher mortality and more severe clinical outcome in patients with infection-associated ALI.
Authors: Sanjay Manocha; James A Russell; Ainsley M Sutherland; Anan Wattanathum; Keith R Walley Journal: J Infect Date: 2006-11-20 Impact factor: 6.072
Authors: Lorraine B Ware; Eric Camerer; Karen Welty-Wolf; Marcus J Schultz; Michael A Matthay Journal: Am J Physiol Lung Cell Mol Physiol Date: 2006-04-28 Impact factor: 5.464
Authors: K Przybyłowska; K Smolarczyk; A Kulig; H Romanowicz-Makowska; A Dziki; J Ulańska; B Pander; J Błasiak Journal: Cancer Lett Date: 2002-07-08 Impact factor: 8.679
Authors: George D Leikauf; Hannah Pope-Varsalona; Vincent J Concel; Pengyuan Liu; Kiflai Bein; Annerose Berndt; Timothy M Martin; Koustav Ganguly; An Soo Jang; Kelly A Brant; Richard A Dopico; Swapna Upadhyay; Y P Peter Di; Qian Li; Zhen Hu; Louis J Vuga; Mario Medvedovic; Naftali Kaminski; Ming You; Danny C Alexander; Jonathan E McDunn; Daniel R Prows; Daren L Knoell; James P Fabisiak Journal: Am J Respir Cell Mol Biol Date: 2012-03-23 Impact factor: 6.914
Authors: Jason D Christie; Mark M Wurfel; Rui Feng; Grant E O'Keefe; Jonathan Bradfield; Lorraine B Ware; David C Christiani; Carolyn S Calfee; Mitchell J Cohen; Michael Matthay; Nuala J Meyer; Cecilia Kim; Mingyao Li; Joshua Akey; Kathleen C Barnes; Jonathan Sevransky; Paul N Lanken; Addison K May; Richard Aplenc; James P Maloney; Hakon Hakonarson Journal: PLoS One Date: 2012-01-25 Impact factor: 3.240
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2009-01-06 Impact factor: 17.440